@PredictaBiosciences
@PredictaBiosci
Followers
18
Following
1
Media
19
Statuses
24
Predicta Biosciences specializes in innovative cancer diagnostics, providing advanced genomic solutions to personalize and improve patient treatment decisions.
Cambridge, MA
Joined August 2024
Our team, led by François Aguet, is thrilled to share that GenoPredicta, our WGS test, shows 100% concordance between bone marrow and blood samples. We've pinpointed key resistance mechanisms impacting therapeutic targets like BCMA and GPRC5D—moving towards blood-based testing
0
0
0
Our innovative blood test offers 100% concordance with traditional FISH-based tests and provides the same insights from a simple blood draw as from bone marrow. With GenoPredicta, clinicians can better detect key genetic alterations and guide personalized treatment plans. Learn
0
0
0
Comprehensive characterization of multiple myeloma genomes from BM or PB w/ novel clinical assay [GenoPredicta] = ID of resistance mechanisms [Nov 3, 2025] @BrunoPaiva_UNAV et al @myelomaMD #ASH25 abs25-14403 PID2586 https://t.co/6jbiTS6Aa9
#mmsm #cagenome #oncopath #LiquidBiopsy
0
4
8
Circulating tumor cells (CTCs) improve risk stratification according to R2-ISS and the IMS-IMWG CGS in NDMM: An analysis from the european CTC consortium [Nov 3, 2025] @Dagostino_MD et al. #ASH25 abs25-12860 PID 364 https://t.co/IXDuMCsqYf
#mmsm #cactc
0
4
10
Exciting news! @PredictaBio is attending #ASH25! We'll be presenting a poster showcasing GenoPredicta, our whole genome sequencing assay for myeloma—validated for both bone marrow and blood samples. Achieving 100% accuracy in detecting key genetic abnormalities and resistance
0
1
3
0
0
0
Predicta is redefining cancer diagnostics with GenoPredicta—a comprehensive, non-invasive whole genome sequencing test for multiple myeloma that works on blood or bone marrow. It helps clinicians make personalized treatment decisions faster and more accurately.
1
0
0
🚀This Multiple Myeloma Awareness Month, we're dedicated to pushing the boundaries of innovation to improve patient outcomes. 🌟 Learn more about our commitment to cutting-edge solutions here at @PredictaBiosci . 🔬 #MyelomaAwarenessMonth
0
0
1
This week, our team gathered to focus on this year's goals. We are inspired and very excited about the work ahead and the impactful data we will generate to support both patients and clinicians.
0
1
4
Last night was above par as we celebrated the holiday spirit with our incredible team & had fun putting around! Celebrating the achievements of 2024 and excited for what the future holds. Wishing everyone a joyful holiday season and a prosperous year ahead!
0
0
0
🌟Welcome to Predicta Biosciences, @JulianMHess🌟 Julian joins Predicta Biosciences as Principal Computational Biologist, bringing expertise from @getz_lab @broadinstitute. We're thrilled to have him on board to advance our mission of impactful patient solutions!
0
0
0
Happy Thanksgiving from @PredictaBiosci! Our recent lunch was a wonderful opportunity to celebrate! During this season of gratitude, we want to thank our investors, clinicians, partners,& especially patients for your support. Wishing everyone a joyful & fulfilling holiday!
0
0
0
Aparna Raval, PhD, SVP of Translational Research, will attend the upcoming #ASH24. If you are interested in learning more about GenoPredicta and Immunopredicta platforms for multiple myeloma and other hematological malignancies, please email us info@predictabiosciences.com
0
0
0
A huge thank you to the BrightEdge - @AmericanCancer for hosting such impactful events & to Farnaz Bakhshi for moderating a fantastic session. It was a true pleasure to meet ACS President Karen Knudsen MBA, PhD. Thank you to @wilsonsonsini, for your support and sponsorship!
0
0
1
Thrilled to have been part of the recent Myeloma Committee, where Valentina Nardi delivered an insightful presentation on our work! A big thank you to @szusmani for the kind invitation. We are inspired by the innovative trials being conducted in the myeloma space!
Welcome to Day 1 - 2024 @ALLIANCE_org Fall Hybrid Group Meeting! Myeloma Committee at 10a CT, Patient Advocate Committee at 2p CT, followed by Audit Workshop at 5:30p CT, with administrative meetings in between. Strong start to three full days! #AllianceFall24 #NCI #NCTN #NCORP
0
1
2
Next week, we’re thrilled to be participating in events hosted by Brightedge - @AmericanCancer 🌟Monday: BrightEdge Entrepreneurs Pitch 🌟Tuesday: Join Kate Caves & industry leaders for a Panel Discussion, Fostering Founders & Entrepreneurs Across the Innovation Impasse
0
0
0
🌟 Inspiring Insights from the Cancer Diagnostics Panel @ the Oncology Venture, Innovation & Partnering Summit! 🌟 🔑 Key Takeaway Harnessing Multi-omics for Precision Medicine Thanks to Mara Aspinall, Tom Miller, Lisa Alderson, Anthony Chang, Alan Hirzel, and Darshana Zaveri
0
0
0
We had the pleasure of attending the #ToughTechSummit, where Kate Caves delivered an inspiring talk on innovations to enhance diagnostic capabilities and advance treatments for diseases like multiple myeloma. 💡🔬 A huge thanks to @theEngineAccelerator & @engineventures !
0
0
0